课题基金 / 基金详情

Reducing Disparities for the Uninsured: Identifying Opportunities for Improved Coverage Through Emergency Medicaid Programs

Reducing Disparities for the Uninsured: Identifying Opportunities for Improved Coverage Through Emergency Medicaid Programs
减少未参保人群的差异:通过紧急医疗补助计划寻找改善覆盖范围的机会
批准号:
10458686
负责人:
Lisa Marie Knowlton
金额:
$19.71万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-07-29 至 2024-04-30

项目摘要

项目成果

Lisa Marie Knowlton的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT The COVID-19 pandemic and racial justice movements have laid bare the structural problems in our healthcare system. Lack of health insurance directly impacts health care access and outcomes. Uninsured patients have catastrophic expenditures, higher rates of mortality, and more limited access to post-discharge resources that are critical for returning to work. These negative impacts are exacerbated among racial and ethnic minorities. We have an unprecedented and timely opportunity to study the uninsured in our nation. At the end of 2018, nearly 14% of the US population were uninsured, a number that has further increased with spikes in unemployment related to COVID-19. There is an urgent need to reduce insurance disparities. A potential solution, Hospital Presumptive Eligibility (HPE), enables hospitals to apply for emergency insurance for uninsured patients. HPE provides temporary Medicaid coverage (up to 60 days), but subsequently enables patients to enroll in Medicaid in order to continue coverage. In light of COVID-19, several states are broadening their HPE eligibility criteria. Little is currently known about factors influencing HPE acquisition, as well as Medicaid enrollment post-HPE and its association with access to care. In our preliminary work, minority patients, those with greater clinical severity, and patients requiring post-discharge services (including rehabilitation, long-term care) were all more likely to be approved for HPE. Among approximately 1000 HPE approved patients in 2018 at our institution, only 53% of those enrolled in Medicaid. We hypothesize that there are modifiable patient- and system-level barriers inhibiting Medicaid enrollment after HPE. As administrative and clinical registry data capture neither HPE approval nor Medicaid enrollment, we will analyze novel customized insurance datasets through the California Department of Health Care Services (DHCS) to evaluate HPE programs and identify improvement opportunities. The proposed work will be accomplished through 2 specific aims: (SA1) Among eligible HPE-approved patients, we will determine the sociodemographic, clinical and hospital factors associated with post-HPE Medicaid enrollment, and (SA2) to understand patients' experiences of process factors that contributed to or impeded enrollment in Medicaid following HPE approval. The time of hospitalization can be leveraged to acquire sustainable insurance coverage that improves patients' long-term health outcomes and reduces their risk of catastrophic health expenditures. Our study evaluates how HPE programs can best be targeted toward improving health outcomes and access to care, particularly among vulnerable minority patients.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Increasing Medicaid Acquisition and Sustainment among the Uninsured
  • 批准号:
    10742494
  • 项目类别:
  • 资助金额:
    $68.08万
  • 财政年份:
    2023
  • 负责人:
    Lisa Marie Knowlton
  • 依托单位:
Reducing Disparities for the Uninsured: Identifying Opportunities for Improved Coverage Through Emergency Medicaid Programs
  • 批准号:
    10287318
  • 项目类别:
  • 资助金额:
    $23.66万
  • 财政年份:
    2021
  • 负责人:
    Lisa Marie Knowlton
  • 依托单位:
国内基金
海外基金
CEACAM5调控Galectin-9介导的CD4+T细胞极化在COVID-19肠屏障损伤的作用机制研究
  • 批准号:
    82370569
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    李啸峰
  • 依托单位:
COVID-19疫情对我国儿童生长发育影响的异质性研究
  • 批准号:
    42371429
  • 项目类别:
    面上项目
  • 资助金额:
    52.00万元
  • 批准年份:
    2023
  • 负责人:
    张知新
  • 依托单位:
传染病模型的稳态切换过程研究及其在治疗COVID-19中的应用
  • 批准号:
    LQ23A010016
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2023
  • 负责人:
    罗敏
  • 依托单位:
“湿漫膜原”视角下研究加味达原饮重塑COVID-19“免疫炎症稳态”的分子机制:TLR4介导IRF3/NF-κB通路串扰
  • 批准号:
    82374291
  • 项目类别:
    面上项目
  • 资助金额:
    48万元
  • 批准年份:
    2023
  • 负责人:
    张传涛
  • 依托单位: